Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABEONA THERAPEUTICS INC.ABEO · Entity 5808 | Director | September 26, 2022 | September 28, 2022 |
| AETERNUM HEALTH, INC.AETN · Entity 7865 | Director · CEO · 10% owner | June 30, 2026 | July 15, 2026 |
| ASP Isotopes Inc.ASPI · Entity 5371 | Director · Chairman and CEO | September 02, 2026 | September 05, 2026 |
| Healthtech Solutions, Inc./UTHLTT · Entity 121972 | Director | November 10, 2021 | November 30, 2022 |
| Illumination Acquisition Corp. IILLU · Entity 5913 | Director | February 26, 2026 | February 26, 2026 |
| POLARITYTE, INC.PTE · Entity 117561 | Chief Financial Officer | March 31, 2020 | April 02, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABEONA THERAPEUTICS INC.
Report date September 26, 2022 · Filed September 28, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,907 |
Reported balance
After 2022-09-26 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-09-26 · Grant · Acquired 13,400 · Balance 16,907 F1: All of the restricted stock will vest on September 26, 2023. F2: On July 1, 2022, the issuer effectuated a 1-for-25 reverse stock split. |
Filing footnotes · ownership attribution and instrument terms
F1: All of the restricted stock will vest on September 26, 2023.
F2: On July 1, 2022, the issuer effectuated a 1-for-25 reverse stock split.
AETERNUM HEALTH, INC.
Report date June 30, 2026 · Filed July 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 49,000,000 |
Reported balance
Holding disclosure · report date 2026-06-30 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 49,000,000 F1: The shares were issued in connection with a reverse merger agreement between Aeternum Health, LLC and Shorepower Technologies, Inc. |
| Preferred StockSEC Table I · non-derivative | Direct | 2,000,000 |
Reported balance
Holding disclosure · report date 2026-06-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,000,000 F1: The shares were issued in connection with a reverse merger agreement between Aeternum Health, LLC and Shorepower Technologies, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were issued in connection with a reverse merger agreement between Aeternum Health, LLC and Shorepower Technologies, Inc.
ASP Isotopes Inc.
Report date September 02, 2026 · Filed September 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,328,570 |
Ending reported balance
After 2026-09-04 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-09-02 · Sale · Disposed 83,758 · Balance 9,496,087 F1: Represents "sell to cover" sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 30, 2025 to cover tax withholding obligations in connection with the quarterly vesting of a restricted stock award. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.75 to $3.96, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Row 2 · 2026-09-03 · Sale · Disposed 83,758 · Balance 9,412,329 F1: Represents "sell to cover" sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 30, 2025 to cover tax withholding obligations in connection with the quarterly vesting of a restricted stock award. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.875 to $3.98, inclusive. The reporting person undertakes to provide the Company, any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Row 3 · 2026-09-04 · Sale · Disposed 83,759 · Balance 9,328,570 F1: Represents "sell to cover" sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 30, 2025 to cover tax withholding obligations in connection with the quarterly vesting of a restricted stock award. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.925 to $4.26, inclusive. The reporting person undertakes to provide the Company, any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents "sell to cover" sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 30, 2025 to cover tax withholding obligations in connection with the quarterly vesting of a restricted stock award.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.75 to $3.96, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.875 to $3.98, inclusive. The reporting person undertakes to provide the Company, any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.925 to $4.26, inclusive. The reporting person undertakes to provide the Company, any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Healthtech Solutions, Inc./UT
Report date November 10, 2021 · Filed November 30, 2022 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,666,667 |
Last balance in matching sequence
After 2022-11-22 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2021-11-10 · Grant · Acquired 1,500,000 · Balance 1,500,000 F1: The award was for no consideration other than services as a member of the Board of Directors. Row 2 · 2022-06-30 · Exercise / conversion · Acquired 166,667 · Balance 1,666,667 F2: The award was for no consideration other than services as a member of the Board of Directors. Row 3 · 2022-11-22 · Grant · Acquired 1,000,000 · Balance 2,666,667 F3: The award was for no consideration other than services as a member of the Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: The award was for no consideration other than services as a member of the Board of Directors.
F2: The award was for no consideration other than services as a member of the Board of Directors.
F3: The award was for no consideration other than services as a member of the Board of Directors.
Illumination Acquisition Corp. I
Report date February 26, 2026 · Filed February 26, 2026
This filing explicitly reported no securities owned.
POLARITYTE, INC.
Report date March 31, 2020 · Filed April 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 415,953 |
Reported balance
After 2020-03-31 transaction · row 1
1 source rowRow 1 · 2020-03-31 · Sale · Disposed 23,158 · Balance 415,953 F1: The reported sale was effectuated pursuant to a 10b5-1 trading plan adopted by the reporting person on September 12, 2019, as amended November 19, 2019. The sale is intended to cover withholding taxes resulting from vesting of restricted stock units that were previously reported on Table I. F2: The reported price is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.00 to $1.145, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price that was included in the calculation of the weighted average price. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported sale was effectuated pursuant to a 10b5-1 trading plan adopted by the reporting person on September 12, 2019, as amended November 19, 2019. The sale is intended to cover withholding taxes resulting from vesting of restricted stock units that were previously reported on Table I.
F2: The reported price is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.00 to $1.145, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price that was included in the calculation of the weighted average price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2020 Filed Jun 19, 2020 20:15 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 45,566 | $0.00 Strike: $3.03 | $0.00 |
DisclosureSEC source: 0001493152-20-011508 · ownership.xml · derivative · entry 2 Mann Paul Elliot · CIK 0001744816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,566 Underlying: Common Stock · 45,566 shares Expires 2030-06-17 F2 · derivative.exercise_date: All of the stock options will vest on December 17, 2020. Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 20:15 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantCommon Stock | 37,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-011508 · ownership.xml · nonDerivative · entry 1 Mann Paul Elliot · CIK 0001744816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,954 F1 · shares: All of the restricted stock will vest on December 17, 2020. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 16:30 UTC | POLARITYTE, INC. PTE · Entity 117561 | SaleCommon Stock | 23,158 | $1.04 | $24,084.32 |
DisclosureSEC source: 0001493152-20-005709 · ownership.xml · nonDerivative · entry 1 Mann Paul Elliot · CIK 0001744816 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,953 F1 · kind: The reported sale was effectuated pursuant to a 10b5-1 trading plan adopted by the reporting person on September 12, 2019, as amended November 19, 2019. The sale is intended to cover withholding taxes resulting from vesting of restricted stock units that were previously reported on Table I. F2 · price: The reported price is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.00 to $1.145, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price that was included in the calculation of the weighted average price. Read SEC document |
| March 23, 2020 Filed Mar 25, 2020 21:05 UTC | POLARITYTE, INC. PTE · Entity 117561 | SaleCommon Stock | 1,283 | $1.05 | $1,347.15 |
DisclosureSEC source: 0001493152-20-004749 · ownership.xml · nonDerivative · entry 1 Mann Paul Elliot · CIK 0001744816 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 439,111 F1 · kind: The reported sale was effectuated pursuant to a 10b5-1 trading plan adopted by the reporting person on September 12, 2019, as amended November 19, 2019. The sale is intended to cover withholding taxes resulting from vesting of restricted stock units that were previously reported on Table I. Read SEC document |
| February 07, 2020 Filed Feb 7, 2020 21:30 UTC | POLARITYTE, INC. PTE · Entity 117561 | SaleCommon Stock | 12,833 | $3.02 | $38,755.66 |
DisclosureSEC source: 0001493152-20-001829 · ownership.xml · nonDerivative · entry 1 Mann Paul Elliot · CIK 0001744816 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,393 F1 · kind: The reported sale was effectuated pursuant to a 10b5-1 trading plan adopted by the reporting person on September 12, 2019, as amended November 19, 2019. The sale is intended to cover withholding taxes resulting from vesting of 29,167 restricted stock units that were previously reported on Table I. F2 · price: The reported price is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.95 to $3.13, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price that was included in the calculation of the weighted average price. Read SEC document |
| December 23, 2019 Filed Dec 23, 2019 20:12 UTC | POLARITYTE, INC. PTE · Entity 117561 | SaleCommon Stock | 11,000 | $2.71 | $29,810.00 |
DisclosureSEC source: 0001493152-19-019668 · ownership.xml · nonDerivative · entry 1 Mann Paul Elliot · CIK 0001744816 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 453,227 F1 · kind: The reported sale was effectuated pursuant to a 10b5-1 trading plan adopted by the reporting person on September 12, 2019. The sale is intended to cover withholding taxes resulting from vesting of 25,000 restricted stock units that were previously reported on Table I. F2 · price: The reported price is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.53 to $2.78, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price that was included in the calculation of the weighted average price. Read SEC document |
| September 23, 2019 Filed Sep 25, 2019 16:54 UTC | POLARITYTE, INC. PTE · Entity 117561 | SaleCommon Stock | 1,283 | $4.30 | $5,516.90 |
DisclosureSEC source: 0001493152-19-014555 · ownership.xml · nonDerivative · entry 1 Mann Paul Elliot · CIK 0001744816 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,227 F1 · kind: The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2019. The sale is intended to cover withholding taxes resulting from vesting of restricted stock awards. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 17:00 UTC | POLARITYTE, INC. PTE · Entity 117561 | GrantCommon Stock | 175,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-011919 · ownership.xml · nonDerivative · entry 1 Mann Paul Elliot · CIK 0001744816 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 465,510 Read SEC document |
| June 28, 2019 Filed Jul 1, 2019 18:41 UTC | POLARITYTE, INC. PTE · Entity 117561 | GrantCommon Stock | 140,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-010063 · ownership.xml · nonDerivative · entry 1 Mann Paul Elliot · CIK 0001744816 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,510 Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 16:30 UTC | POLARITYTE, INC. PTE · Entity 117561 | Tax withholdingCommon Stock | 6,088 | $5.86 | $35,675.68 |
DisclosureSEC source: 0001493152-19-009571 · ownership.xml · nonDerivative · entry 1 Mann Paul Elliot · CIK 0001744816 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,159 F1 · shares: Reporting person was granted 100,000 Restricted Stock Units on June 20, 2018 that vest in four equal installments every six months. Each Restricted Stock Unit converts to one share of common stock. 25,000 restricted stock units vested June 20, 2019 when the fair value of the common stock was $5.86, and the issuer withheld from the reporting person 6,088 shares valued at $5.86 per share to cover the income tax withholding amount arising from the vesting event. Read SEC document |
| June 05, 2019 Filed Jun 6, 2019 09:25 UTC | POLARITYTE, INC. PTE · Entity 117561 | PurchaseCommon Stock | 35,000 | $5.33 | $186,518.50 |
DisclosureSEC source: 0001493152-19-008788 · ownership.xml · nonDerivative · entry 1 Mann Paul Elliot · CIK 0001744816 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,247 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.10 to $5.50, inclusive. The reporting person undertakes to provide to PolarityTE, Inc. and any of its security holders, and to the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| March 20, 2019 Filed Mar 21, 2019 17:08 UTC | POLARITYTE, INC. PTE · Entity 117561 | Tax withholdingCommon Stock | 865 | $12.52 | $10,829.80 |
DisclosureSEC source: 0001493152-19-003727 · ownership.xml · nonDerivative · entry 1 Mann Paul Elliot · CIK 0001744816 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,247 F1 · security: The Reporting Person was granted a Restricted Stock Unit award for 11,667 shares on September 20, 2018, which vests in four installments every six months beginning March 20, 2019. On March 20, 2019, 2,917 shares vested and the Issuer retained 865 shares for withholding taxes. Read SEC document |
| January 24, 2019 Filed Feb 11, 2019 16:30 UTC | POLARITYTE, INC. PTE · Entity 117561 | Tax withholdingCommon Stock | 9,555 | $16.20 | $154,791.00 |
DisclosureSEC source: 0001493152-19-001703 · ownership.xml · nonDerivative · entry 1 Mann Paul Elliot · CIK 0001744816 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,112 Read SEC document |
| September 20, 2018 Filed Sep 24, 2018 17:31 UTC | POLARITYTE, INC. PTE · Entity 117561 | GrantEmployee Stock Option (Right to Buy) · Derivative | 21,665 | $0.00 Strike: $20.12 | $0.00 |
DisclosureSEC source: 0001493152-18-013693 · ownership.xml · derivative · entry 2 Mann Paul Elliot · CIK 0001744816 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,665 Underlying: Common Stock · 21,665 shares Expires 2028-09-19 F1 · derivative.exercise_date: The option vests in 24 equal monthly installments beginning on October 20, 2018. Read SEC document |
| September 20, 2018 Filed Sep 24, 2018 17:31 UTC | POLARITYTE, INC. PTE · Entity 117561 | GrantCommon Stock | 11,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-18-013693 · ownership.xml · nonDerivative · entry 1 Mann Paul Elliot · CIK 0001744816 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,667 Read SEC document |
| September 18, 2018 Filed Sep 19, 2018 09:15 UTC | POLARITYTE, INC. PTE · Entity 117561 | PurchaseCommon Stock | 20,000 | $17.24 | $344,716.00 |
DisclosureSEC source: 0001493152-18-013438 · ownership.xml · nonDerivative · entry 1 Mann Paul Elliot · CIK 0001744816 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 F1 · price: Represents the weighted average price for multiple purchases on the same day, all within a price range between $17.065 and $17.31. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.